Ignite Creation Date:
2024-05-06 @ 11:06 AM
Last Modification Date:
2024-10-26 @ 12:40 PM
Study NCT ID:
NCT03434158
Status:
COMPLETED
Last Update Posted:
2022-11-03
First Post:
2018-01-26
Brief Title:
Olaparib Maintenance in Patients With MCRPC After Docetaxel Treatment Reaching Partial or Stable Response IMANOL
Sponsor:
Spanish Oncology Genito-Urinary Group
Organization:
Spanish Oncology Genito-Urinary Group
Organization Data
Organization:
Spanish Oncology Genito-Urinary Group
Class:
OTHER
Study ID:
SOGUG-2016-A-IECPRO-12
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Spanish Oncology Genito-Urinary Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| AstraZeneca | INDUSTRY |
| Apices Soluciones SL | INDUSTRY |